Literature DB >> 21537121

To pee or not to pee: ammonia hypothesis of hepatic encephalopathy revisited.

Liliane Mpabanzi1, Steven W M Olde Damink, Marcel C G van de Poll, Peter B Soeters, Rajiv Jalan, Cees H C Dejong.   

Abstract

Hepatic encephalopathy is a neuropsychiatric syndrome associated with liver failure. Its aetiology has been debated for the past 100 years. Nevertheless, elevated ammonia levels are still believed to play a central role in its pathogenesis. After intestinal production, ammonia is detoxified by the liver. In liver failure, skeletal muscle and brain have been proposed to be alternative, although temporary, ammonia detoxifying organs. However, there is an increasing body of evidence that the kidney, in addition to the gut, is a pivotal organ determining systemic ammonia levels. In the last 20 years, it has been shown that the kidney can switch from an organ of systemic net ammonia production to a net ammonia excretion organ. The kidney plays a central role in the determination of ammonia levels. It is at least as important as the gut and could therefore serve as a target for new treatments for hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537121     DOI: 10.1097/MEG.0b013e328346a7bd

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  Clinical utility of breath ammonia for evaluation of ammonia physiology in healthy and cirrhotic adults.

Authors:  Lisa A Spacek; Matthew Mudalel; Frank Tittel; Terence H Risby; Steven F Solga
Journal:  J Breath Res       Date:  2015-12-14       Impact factor: 3.262

2.  Fast and accurate exhaled breath ammonia measurement.

Authors:  Steven F Solga; Matthew L Mudalel; Lisa A Spacek; Terence H Risby
Journal:  J Vis Exp       Date:  2014-06-11       Impact factor: 1.355

3.  Hepatic encephalopathy associated with cancer or anticancer therapy.

Authors:  Kaspar J Willson; Louise M Nott; Vy T Broadbridge; Timothy Price
Journal:  Gastrointest Cancer Res       Date:  2013-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.